Bilyk I. Pharmacoeconomic justification for perfection of medicinal supplying of children with childhood bacterial infectious

The dissertation deals with the scientific research to form approaches to the pharmacoeconomic rationale for the improvement of pharmacological support of children suffering from childhood bacterial infections (CBI). The marketing analysis of azithromycin (J01FA10) and cefotaxime (J01DD01), which are recommended for patients with CBI, was performed by monthly monitoring. Assessment of socio-economic affordability of azithromycin, cefotaxime by monitoring of liquidity ratios (Cliq), adequacy of the population paying capacity (Ca.s), and affordability (A) of drugs allows considering them affordable for an average family in Ukraine with a child suffering from a childhood infectious disease. There is a lack of available and affordable vaccines for the prevention of CBI (pertussis, MI), which deprives parents of the opportunity to vaccinate their children at their own expense in a timely manner. According to an anonymous survey of physicians, an expert assessment of AB administered to children with CBI was carried out.